Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Tag Archives: Foreign direct investment
Multinationals and Monopolies: Pharmaceutical Industry in India after TRIPS
One of the basic apprehensions of the re-introduction of product patent protection in pharmaceuticals in India has been that product monopolies will lead to very high prices. While high prices have been reported from time to time, no systematic studies were available. This … Continue reading
Posted in Drug Pricing, Generic drug, patent, Sec 3 (d), TRIPS
Tagged Foreign direct investment, Novartis
2 Comments
BIT(s) by bit
by Shalini Bhutani | November 09, 2011 Source: mylaw.net Bilateral investment treaties (“BITs”) and other free trade agreements (“FTAs”) have emerged as the way forward for countries to craft their trade and economic relations. BITs are intended to facilitate the … Continue reading
Industry ministry opposes allowing brownfield investment through auto route
NEW DELHI: The Department of Industrial Policy and Promotion has raised serious doubts on the suitability of India’s competition authority to oversee acquisition of local firms by multinational drug companies. In a note of dissent addressed to the High Level … Continue reading
Sharma writes to PM on pharma M&A concerns
Minister seeks ‘procedural filter’ on investments by foreign companies in Indian pharmaceutical firms Asit Ranjan Mishra The Livemint, 21 September 2011 India’s commerce and industry ministry is getting serious with its effort to have all foreign investment in Indian pharmaceutical … Continue reading
Posted in FDI, Mergers and Acquisitions
Tagged Anand Sharma, Foreign direct investment, Planning Commission
Leave a comment
Indian industry warns of ‘incapacitating’ effect of large foreign takeovers
Scrip Magazine 30 August 2011 Anju Ghangurde Second rung Indian firms, which account for less than 20% of the country’s pharmaceutical exports, cannot fill the shoes of first tier companies if the latter continue to be acquired by foreign firms, … Continue reading
Planning Commission endorses 100% FDI in pharmaceutical sector
Industry groups backed by domestic players have been seeking restrictions on mergers and acquisitions arguing that India would turn into a contract manufacturing centre and would lose its edge. Another concern is that prices of medicines will increase due to lack of … Continue reading
Posted in FDI, Generic drug
Tagged Foreign direct investment, Montek Singh Ahluwalia
Leave a comment
